Novozymes A/S Financials

Novozymes A/S Stock Summary

Novozymes A/S competes with Symrise Ag, Givaudan, Sika AG, Sika AG, and LAir Liquide. Novozymes AS produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark. NOVOZYMES is traded on OTC Exchange in the United States.

Novozymes A/S Key Financial Ratios

There are many critical financial ratios that Novozymes A/S's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Novozymes AS B reports annually and quarterly.

Novozymes Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Novozymes A/S's current stock value. Our valuation model uses many indicators to compare Novozymes A/S value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Novozymes A/S competition to find correlations between indicators driving Novozymes A/S's intrinsic value. More Info.Novozymes AS B is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about  0.38  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Novozymes AS B is roughly  2.63 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Novozymes A/S's earnings, one of the primary drivers of an investment's value.

Novozymes AS B Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Novozymes A/S help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Novozymes AS B. We use our internally-developed statistical techniques to arrive at the intrinsic value of Novozymes AS B based on widely used predictive technical indicators. In general, we focus on analyzing Novozymes Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Novozymes A/S's daily price indicators and compare them against related drivers.

When running Novozymes A/S's price analysis, check to measure Novozymes A/S's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novozymes A/S is operating at the current time. Most of Novozymes A/S's value examination focuses on studying past and present price action to predict the probability of Novozymes A/S's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novozymes A/S's price. Additionally, you may evaluate how the addition of Novozymes A/S to your portfolios can decrease your overall portfolio volatility.